Florida Medical Center Acquires New Technology to Treat Paroxysmal Atrial FibrillationMar 12, 2018
The minimally invasive system can potentially reduce procedure times and provide better treatment outcomes.
Fort Lauderdale, Fla. (November 25, 2015) — The Arctic Front Advance Cryoballoon System at Florida Medical Center may give hope to patients suffering from paroxysmal atrial fibrillation (PAF), a condition in which irregular heartbeats in the upper chambers start and stop suddenly on their own, usually for minutes or days at a time.
“This technology can help give patients peace of mind that following treatment, they will be able to resume their normal, daily activities,” said Gabrielle Finley-Hazle, CEO of Florida Medical Center. “As the first hospital to provide open heart surgery in Broward County, The Heart Institute of Florida at Florida Medical Center continually strives to deliver outstanding cardiac care to the community.”
The Arctic Front Advance Cyroballoon System can potentially reduce procedure times and provide better treatment outcomes. The technology is designed to make it easier for physicians to isolate the pulmonary veins and treat patients with complicated anatomies.
The Artic Front Advance Cryoballoon System includes:
- The Cryoballoon, which inflates and fills with coolant to isolate the pulmonary veins for the treatment of PAF
- The FlexCath Advance™ Steerable Sheath, which helps deliver and position the cryoballoon in the left atrium
- The Achieve® Mapping Catheter, an intra-cardiac electrophysiology recording catheter used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation
- The Freezor® MAX Cardiac CryoAblation Catheter, which is a single-point catheter used to provide additional ablations, as needed
- The CryoConsole, which houses the coolant, electrical and mechanical components that run the catheters during a cryoablation procedure
“I am very pleased that this state-of-the art therapy is now available to safely and effectively treat our patients suffering from paroxysmal atrial fibrillation,” said Dr. David Kenigsberg, a clinical cardiac electrophysiologist on the medical staff at Florida Medical Center. “Through published studies, my colleagues and I believe that this procedure is the best way to isolate the pulmonary veins, yielding a very high success rate with a low risk of complications.”
Atrial fibrillation (Afib) is the most common and one of the most undertreated heart rhythm disorders, affecting more than 7 million people worldwide. It is estimated that half of all diagnosed Afib patients fail drug therapy, and if left untreated, patients have up to a five times higher risk of stroke and an increased chance of developing heart failure.
The Heart Institute of Florida at Florida Medical Center remains one of the area’s top heart hospitals. Providing comprehensive cardiac care with its team of highly skilled cardiologists, cardiothoracic surgeons, nurses, physical therapists, respiratory therapists, dietitians, pharmacists and other clinical staff, the Institute boasts an aortic disease institute, a cutting-edge electrophysiology lab, a valve clinic and a hybrid operating room.
To learn more about the heart and vascular services provided at the Heart Institute at Florida Medical Center, visit www.floridamedctr.com/our-services/heart-vascular.